.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Sandra Ciesek

Frankfurt / DE

University Hospital Frankfurt

Vorsitz

30.03.2023
10:30 – 12:00
Plenary Session
Exciting discoveries of young virologists
Lecture hall 4/5

Weitere Beteiligungen

28.03.2023
Poster
P 251
SARS-CoV-2 variants show different host cell proteome profiles with delayed immune response activation in Omicron-infected cells
Innate immunity, SARS-CoV-2
28.03.2023
Poster
P 252
Prevalence of SARS-CoV-2 in companion animals
Emerging viruses and zoonosis, SARS-CoV-2
28.03.2023
Poster
P 027
Development of a liposomal formulation pipeline for inhalation application against SARS-CoV-2
Antiviral therapy and resistance, SARS-CoV-2
28.03.2023
Poster
P 236
Identification of β-catenin/CBP as a host factor for SARS-CoV-2 using machine learning on large scale perturbation screens
Antiviral therapy and resistance, SARS-CoV-2
28.03.2023
Poster
P 237
Molecular analyses of clinical isolates and recombinant SARS-CoV-2 carrying B.1 and B.1.617.2 spike mutations suggest a potential role of non-spike mutations in infection kinetics
SARS-CoV-2, Viral pathogenesis and persistence
28.03.2023
Poster
P 258
Development and characterization of human kidney derived cell models for SARS-CoV-2 infections
Host cell factors and modulation, SARS-CoV-2
28.03.2023
Poster
P 261
Interferon signalling in monocytes exposed to different SARS-CoV-2 variants
Innate immunity, SARS-CoV-2
28.03.2023
Poster
P 078
Prevalence of viremia in SARS-CoV-2 patients from the NAPKON cohort
Clinical virology, Epidemiology and public health
28.03.2023
Poster
P 269
TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection in mice
SARS-CoV-2, Virus receptors and entry
28.03.2023
Poster
P 144
A versatile workflow for early monitoring of SARS-CoV-2 variants in community and aircraft wastewater
Epidemiology and public health, SARS-CoV-2
28.03.2023
Poster
P 247
Omicron-induced interferon signalling prevents influenza A virus infection
Innate immunity, SARS-CoV-2
28.03.2023
Poster
P 080
Drug sensitivity of currently circulating Mpox viruses
Antiviral therapy and resistance, Clinical virology
28.03.2023
Poster
P 081
Repurposing of nitroxoline for the treatment of mpox (monkeypox)
Clinical virology
31.03.2023
11:00 – 11:15 12 Min. 3 Min.
Abstract Talk
O 116
An MCMV-based vaccine expressing full-length parental SARS-CoV-2 spike provides long-lived and broad protection against SARS-CoV-2 variants in mice
SARS-CoV-2, Vaccines